Real-world experience with daclatasvir plus sofosbuvir +/- ribavirin for post-liver transplant HCV recurrence and severe liver disease

Herzer, K.; Welzel, T.M.; Spengler, U.; Hinrichsen, H.; Klinker, H.; Berg, T.; ... ; Zeuzem, S. (2017)

Article / Letter to editor

• Decompensated
• fibrosing cholestatic hepatitis
• HCV therapy
• liver transplant

• All authors: Herzer, K.; Welzel, T.M.; Spengler, U.; Hinrichsen, H.; Klinker, H.; Berg, T.; Ferenci, P.; Peck-Radosavljevic, M.; Inderson, A.; Zhao, Y.; Jimenez-Exposito, M.J.; Zeuzem, S.
• Date: 2017-03-31
• Journal: Transplant International
• Volume: 30
• Issue: 3
• Pages: 243 - 255
• DOI: doi:10.1111/tri.12910